Usta, MDilek, KamilErsoy, AÖzdemir, BMıstık, RVuruşkan, HGüllülü, MYavuz, MOktay, BYurtkuran, M2024-11-142024-11-142002-01-010036-5599https://www.tandfonline.com/doi/abs/10.1080/003655902762467657https://hdl.handle.net/11452/47867Objective: Little is known about the prevalence of transfusion transmitted virus (TTV) infection in renal transplant recipients (RTxs) and its effects on allograft survival. We investigated the prevalence of TTV and its effects on liver injury and graft survival in RTxs.Material and Methods: The study was performed in 33 consecutive RTxs (8 females. 25 males) and 100 blood donors (35 females, 65 males). A nested polymerase chain reaction was used to detect TTV DNA in serum. Serum creatinine and alanine aminotransferase (ALT) levels and 24-h protein excretion were determined in both TTV-positive and -negative patients. The total number of blood transfusions, the duration of hemodialysis and the total duration after transplantation were recorded in RTxs. In addition, hepatitis B surface antigen (HbsAg), anti-hepatitis C virus (HCV) and hepatitis G virus DNA antibodies were determined in all patients.Results: TTV DNA was detected in 51.5% of RTxs and in 7% of the control group and this difference was statistically significant 3<0.01). In the RTx group, 64.7% of TTV-positive and 56.2% of TTV-negative patients had undergone a previous blood transfusion. However, the blood transfusion replacement rate, total duration of dialysis therapy and post-transplant period did not differ between these two groups. Five (15.1%) patients in the RTx group had abnormal liver function tests (ALT >40 IU/l). Of these patients, 2 were anti-HCV-positive, 1 was HBsAg-positive and anti-HCV- plus TTV DNA-positive and the serologic tests of the remaining 2 patients were all negative. Among the TTV-positive patients, 2 (11.7%) were anti-HCV-positive, 1 (5.8%) was HBsAg-positive and 3 (17.6%) were HGV DNA-positive. The baseline serum creatinine levels did not differ significantly between the TTV-positive and -neptive patients, being 1.5 +/- 0.6 and 1.4 +/- 0.6 mg/dl, respectively (p > 0.05). Two of the TTV-positive patients and 1 of the TTV-negative patients had proteinuria. A 1-year follow-up of TTV-positive and -negative patients demonstrated neither acute nor chronic graft rejection.Conclusion: In RTxs, TTV infection was more prevalent than in the normal population. In our patients the virus did not have an important effect on renal graft rejection and did not cause liver injury. However, the question of whether TTV infection may affect graft survival requires further long-term investigation in larger groups.eninfo:eu-repo/semantics/closedAccessHepatitis-c virusTt virusMembranoproliferative glomerulonephritisPosttransfusion hepatitisHemodialysis-patientsUnknown etiologyCytomegalovirusExpressionExcretionGraft survivalKidney transplantationPrevalenceRejectionTransfusion transmitted virusScience & technologyLife sciences & biomedicineUrology & nephrologyArticle000180716300012473477366